1-Methyl-1H-indazole-5-boronic acid is a heterocyclic boronic acid derivative featuring an indazole core substituted with a methyl group at the N1 position and a boronic acid functional group at the 5-position. Boronic acids are pivotal reagents in modern synthetic chemistry, particularly in Suzuki-Miyaura cross-coupling reactions, which are widely employed for the construction of carbon-carbon bonds. Its primary application is as a key pharmaceutical intermediate or building block in medicinal chemistry research and drug discovery. The indazole scaffold is a privileged structure found in numerous bioactive molecules and drug candidates targeting various therapeutic areas, including oncology and central nervous system disorders. The boronic acid group allows for efficient incorporation of this heterocyclic unit into more complex molecular architectures via palladium-catalyzed coupling, facilitating the rapid synthesis of compound libraries for biological screening. As a specialized boronic acid building block, it is not considered a commodity chemical but is valuable for constructing molecules with potential pharmacological activity. Standard safety precautions for handling boronic acids and laboratory chemicals should be observed.